🤖 AI Summary
Current general-purpose pathological foundation models are predominantly trained on non-neural tissue data, limiting their capacity to effectively represent neurospecific structures (e.g., neurons, glial cells) and neuropathological hallmarks (e.g., amyloid plaques, neurofibrillary tangles), thereby impeding AI-driven analysis of neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases. To address this gap, we introduce NeuroFM—the first domain-specific foundation model tailored for whole-slide images (WSIs) of human brain tissue. NeuroFM leverages a large-scale, real-world neurohistopathological WSI dataset and adopts a Vision Transformer architecture trained via contrastive learning–based self-supervision. Extensive experiments demonstrate that NeuroFM significantly outperforms generalist models on downstream tasks including mixed dementia classification, hippocampal segmentation, and cerebellar ataxia subtype identification. These results underscore the critical importance of domain specialization in enhancing the robustness and diagnostic accuracy of AI systems for neuropathology.
📝 Abstract
Foundation models have transformed computational pathology by providing generalizable representations from large-scale histology datasets. However, existing models are predominantly trained on surgical pathology data, which is enriched for non-nervous tissue and overrepresents neoplastic, inflammatory, metabolic, and other non-neurological diseases. Neuropathology represents a markedly different domain of histopathology, characterized by unique cell types (neurons, glia, etc.), distinct cytoarchitecture, and disease-specific pathological features including neurofibrillary tangles, amyloid plaques, Lewy bodies, and pattern-specific neurodegeneration. This domain mismatch may limit the ability of general-purpose foundation models to capture the morphological patterns critical for interpreting neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and cerebellar ataxias. To address this gap, we developed NeuroFM, a foundation model trained specifically on whole-slide images of brain tissue spanning diverse neurodegenerative pathologies. NeuroFM demonstrates superior performance compared to general-purpose models across multiple neuropathology-specific downstream tasks, including mixed dementia disease classification, hippocampal region segmentation, and neurodegenerative ataxia identification encompassing cerebellar essential tremor and spinocerebellar ataxia subtypes. This work establishes that domain-specialized foundation models trained on brain tissue can better capture neuropathology-specific features than models trained on general surgical pathology datasets. By tailoring foundation models to the unique morphological landscape of neurodegenerative diseases, NeuroFM enables more accurate and reliable AI-based analysis for brain disease diagnosis and research, setting a precedent for domain-specific model development in specialized areas of digital pathology.